Myxomatous mitral valve disease is a major problem in canine cardiology. Degenerative changes extend from the valve leaflets to reach the rest of the subvalvular apparatus. The chordae tendineae (CT) play a key role in the mechanics of the mitral valve and ensure unidirectional blood flow through the heart. Degenerative changes within the chordae tendineae can severely disrupt their function, ultimately leading to an episode of chordae rupture. The study aimed to analyse the structure of healthy and degenerated CTs via histopathology and immunohistochemistry. The mitral valve was assessed macroscopically using the Whitney scale to identify degenerative changes. The chordae tendineae were classified on a four-grade scale (0–3) on the basis of structural changes and subsequently analysed through immunohistochemical staining with antibodies targeting collagens I, III, and IV, as well as fibronectin, chondroitin, and tenascin. The findings revealed alterations in the extracellular matrix in degenerated chordae tendineae.
Myxomatous mitral valve disease is the most common cardiac disease among dogs. The mitral valve consists of valve leaflets, chordae tendineae and papillary muscles. Much attention has been given to lesions of the valve leaflets, but there is still a lack of information in the literature about the chordae. During myxomatous mitral valve disease, an episode of chordae rupture can occur. Predisposing factors for such an episode are known in human cardiology. The 54 mitral valves were prepared from the hearts of older dogs, from which the chordae tendineae were then isolated. The chordae tendineae were subjected to two tests: biomechanical and histopathological. The first consisted of a uniaxial tensile test to determine the mechanical strength values of chordae tendineae. The histopathological examination was based on a 4-point scale (0–3 scale), which assessed the extent of degenerative changes within chordae tendineae. The biomechanical and histopathological findings were correlated in the statistical analysis. Degenerated chordae tendineae tended to rupture more rapidly during the static stretching test as compared to healthy chordae. The more advanced the degenerative changes in the chordae tendineae, the more the biomechanical function was affected. Degeneration affects the biomechanical properties of the mitral valve chordae tendineae in dogs, as confirmed by chordae tendineae stress studies.
Radiofrequency catheter ablation is a minimally invasive electrophysiological procedure that utilizes radiofrequency energy to induce targeted thermal injury within arrhythmogenic myocardial tissue, thereby eliminating the substrate responsible for rapid and irregular cardiac rhythm disturbances. Radiofrequency ablation is a method widely used in human medicine for the permanent treatment of arrhythmias. In veterinary medicine, there are only a few centers worldwide that use this treatment method in dogs. This article presents the experiences of a Polish center in treating supraventricular and ventricular arrhythmias using this method. The first electrophysiological study and ablation were performed using an analog electrophysiological system; subsequent procedures were performed with the aid of a computerized system, and the last three procedures were performed using a 3D electroanatomical system. A total of 14 radiofrequency ablation procedures were performed on dogs weighing 10 to 33 kg, aged 9 months to 9 years, of various sexes and breeds. Fifty percent of the dogs that underwent ablation had both clinical and echocardiographic signs of tachycardia-induced cardiomyopathy. Three dogs required a re-ablation procedure. Complete elimination of clinically significant arrhythmias was achieved in 13 of 14 dogs, while one dog showed partial procedural success. No significant or permanent complications were observed in any of the dogs. Radiofrequency ablation procedures for arrhythmias are effective and safe.
Myxomatous mitral valve disease (MMVD) is the most common acquired cardiac disease in small-breed dogs and shows particularly high prevalence and early onset in Cavalier King Charles Spaniels (CKCS). Although MMVD is considered a complex, polygenic disease, the clinical relevance of individual genetic variants remains incompletely understood. The angiotensin-converting enzyme (ACE) gene variant rs850683722 has previously been associated with altered ACE activity and differences in renin–angiotensin–aldosterone system-related responses in dogs with MMVD. The aim of this study was to determine the prevalence of rs850683722 in a Polish population of CKCS dogs and to assess whether this variant is associated with the clinical course of MMVD. A total of 105 CKCS dogs were included in the study. All dogs underwent standardized cardiovascular evaluation, including echocardiography, electrocardiography, and systolic blood pressure measurement. MMVD diagnosis and staging were performed according to current ACVIM consensus criteria. Genotyping of the rs850683722 variant was performed using Sanger sequencing for 95 dogs, while next-generation sequencing data was obtained for 10 dogs. Genotype distribution, allele frequencies, conformity with the Hardy–Weinberg equilibrium (HWE), sex-related differences, and associations between genotype and age at progression to selected MMVD stages or the primary clinical endpoint were assessed statistically. The most frequent genotype was AA, detected in fifty-nine dogs, followed by GG in thirty-seven dogs and AG in nine dogs. When dogs carrying at least one A allele were considered variant-positive, the overall prevalence of the variant-positive genotype was 64.8%. The calculated allele frequencies were 0.605 for the A allele and 0.395 for the G allele. The observed genotype distribution deviated markedly from the Hardy–Weinberg equilibrium, mainly because of a pronounced deficit of heterozygous dogs. No significant association was detected between genotype and sex. Genotype was also not significantly associated with age at progression to stage B2 or stage C. A statistically significant difference in age of death was demonstrated by genotype, but this difference was not reflected in the survival analysis. The rs850683722 variant was highly prevalent in the studied Polish CKCS population, with a frequency comparable to previously reported data for this breed. Despite its documented biological association with ACE activity and RAAS-related responses, the variant was not significantly associated with the clinical progression of MMVD in this cohort. These findings suggest that rs850683722 alone seems unlikely to be a reliable marker for predicting the severity or rate of MMVD progression in Polish CKCS dogs. Further studies including larger cohorts, longer follow-up, pedigree information, and the direct assessment of RAAS activity may help clarify whether this variant has stage-dependent or treatment-related clinical relevance.